Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Endocrinology
•
Bone and Calcium Disorders
•
Male and Female Reproductive Disorders
•
General Endocrinology
How do you view the efficacy of estrogen replacement therapy in trans-women with regards to osteoporosis prevention and treatment?
Related Questions
Is bilateral oophorectomy the first-line treatment for ovarian hyperthecosis?
Should estrogen therapy be initiated in patients with refractory functional hypothalamic amenorrhea to improve bone health?
How do you manage osteoporosis in patients with anorexia nervosa (who often are young women < 40)?
For a patient with idiopathic hypercalciuria and a history of calcium kidney stones who has not normalized 24-hr urine calcium level on thiazide diuretic, is there evidence for targeting a certain urine calcium level for decreased future risk of nephrolithiasis and osteoporosis?
How should patients time the ingestion of their alendronate and levothyroxine given issues with food/drug interactions?
Would you recommend prescribing testosterone replacement therapy to reduce osteoporosis fracture rates in men with hypogonadism?
Would you start anabolic agents for osteoporotic hip fracture healing?
How do you approach treatment of low bone density in very young women with longstanding functional hypothalamic amenorrhea?
How do you perform an monitor a GnRH agonist challenge to aid your evaluation/diagnosis of Progestogen Hypersensitivity (PH)?
Is it safe to use anabolic therapy to treat osteoporosis in patients with gastric neuroendocrine tumor?